Categories for Policy
EPA has published a Federal Register Notice stating that it is extending the review periods for all TSCA Section 5 PMNs, SNUNs, MCANs, and exemption notices that were submitted to the Agency under TSCA section 5 before December 29, 2018 and for which the review period of those notices had not yet expired as of that date. This extension impacts 581 new chemical notifications.
February 5, 2019
January 31, 2019 Office of the Secretary United States International Trade Commission 500 E Street SW Washington, DC 20436 Via... View Article
January 31, 2019
January 31, 2019 Office of the Secretary United States International Trade Commission 500 E Street SW Washington, DC 20436 Via... View Article
January 31, 2019
ARLINGTON, VA – In a major win for the specialty and fine chemical industry, the Society of Chemical Manufacturers & Affiliates (SOCMA) hails the bipartisan passage of legislation in both the House and Senate to reauthorize the Department of Homeland Security’s Chemical Facility Anti-Terrorism Standards (CFATS) program.
January 17, 2019
January 15, 2019 Mr. Edward Gresser Chair of the Trade Policy Staff Committee Office of the U.S. Trade Representative 600... View Article
January 15, 2019
January 15, 2019 Mr. Edward Gresser Chair of the Trade Policy Staff Committee Office of the U.S. Trade Representative 600... View Article
January 15, 2019
After almost three weeks, the government shutdown is having a ripple affect on the Food and Drug Administration’s (FDA) submission of Generic Drug User Fee Act (GDUFA) and other pharmaceutical supply chain user fee programs overseen by the Agency.
January 11, 2019
With the U.S. government shutdown moving into its third week, the Environmental Protection Agency (EPA) has signaled it anticipates delays related to its responsibilities under the Toxic Substances Control Act (TSCA).
January 9, 2019
ARLINGTON, VA – John DiLoreto, Executive Director of the Bulk Pharmaceuticals Task Force and advisor to SOCMA’s PharmaChem Sector, delivered a fresh perspective on the pharmaceutical supply problem as a trickle-down effect of multiple factors within the fine and specialty chemical sector during a panel discussion on Manufacturing and Supply Challenges in Washington, D.C.
November 29, 2018
U.S. Chemical Safety Board 1750 Pennsylvania Avenue, NW Suite 910 Washington, DC 20006 combustibledust@csb.gov Re: CSB Releases Call to Action... View Article
November 20, 2018